Business Case

Business development scan and prioritization of potential Rheumatology assets for acquisition or in-licensing

Our client, a top biopharma company, endured significant failures in their Rheumatology portfolio which presented significant gaps in project revenue and increased their focus on business development activities. To support and guide these efforts, LSC was able to help identify possible Rheumatology acquisition/licensing targets and implement and execute a process to filter and prioritize the targets. This enabled client BD team to engage with a finite set of target companies.